KAT2B and coronary artery disorder: It has been found that variations in the KAT2B gene promoter can reduce the risk of coronary heart disease mortality and restenosis [21], and the heterozygous for the low-risk allele patients had about 20 present lower risks of the cardiovascular events and homozygous allele individuals had about 40 present lower risks [21].